Duolingo vs. Zeta Global: Which Technology Stock Is a Better Buy in 2026?

The article contrasts Duolingo (FY2025 revenue ~$1.0B, net income ~$414.1M, net margin ~39.9%, forward P/E 42.9x) versus Zeta Global (FY2025 revenue ~$1.3B, net loss ~$31.5M, net margin ~-2.4%, forward P/E 19.9x). It highlights AI-driven growth optionality for Zeta via a Palantir partnership, but flags profitability risk and heavy customer concentration, while Duolingo is more profitable yet exposed to app-store concentration, possible competitive disruption from gen-AI, and an April 2026 securities-law investigation. Overall, it frames Zeta as the more valuation-attractive AI play (lower multiples) but with weaker net economics, suggesting limited near-term clarity on which will outperform.

Analysis

This is less a “cheap vs expensive” debate than a quality-vs-optional upside call. DUOL’s core asset is efficient consumer monetization with a real margin profile; the market risk is not bankruptcy, it’s that app-distribution gatekeepers and AI-native substitutes can slow paid conversion before the slowdown shows up in reported revenue. ZETA is the opposite: a lower multiple is deserved if customer concentration and SBC prevent clean compounding, and the Palantir tie-up is more narrative validation than near-term P&L uplift.

Near term, the tape should be driven by earnings revisions and any legal/regulatory headline rather than product commentary. DUOL’s first downside leg would likely come from a growth re-rate if conversion or engagement softens; ZETA’s downside is more brittle because one or two large account hiccups can reset estimates quickly. Over 6-18 months, privacy tightening and enterprise AI adoption should favor vendors with durable first-party data and strong workflow integration — that helps the category, but it does not automatically make ZETA the winner.

Consensus appears to be underestimating how much of ZETA’s “cheapness” is offset by SBC dilution and concentration risk, while also overstating the immediacy of AI substitution risk at DUOL. The cleaner relative trade is to own the higher-quality compounder only on pullbacks and treat the lower-multiple name as a show-me story until retention and SBC improve materially. Falsifiers: DUOL sustaining >30% growth with stable margins would validate the bull case; ZETA showing two straight quarters of improving net retention and falling SBC as a share of cash flow would justify multiple expansion.

Key Decisions for Investors

• Initiate a small long DUOL / short ZETA pair over the next 1-2 earnings cycles; target 10-15% relative outperformance if DUOL growth stays >30% and ZETA fails to convert AI narrative into cleaner margins. Stop if ZETA demonstrates sustained retention improvement and SBC compression for two quarters.
• Do not buy ZETA outright as a "value" software name until the company proves that free cash flow is not being propped up by SBC add-backs; require a visible step-down in SBC as % of operating cash flow before upgrading.
• Use DUOL weakness post-earnings or on investigation-related headlines to add selectively rather than preemptively; the risk/reward improves if the forward multiple compresses 15-20% without a corresponding break in revenue growth.
• Watch PLTR as the cleaner beneficiary of the enterprise-AI narrative implied by the ZETA partnership; any order-flow or guidance acceleration at PLTR is a higher-conviction expression than owning ZETA on partnership optimism alone.